Participants Needed for a Study of a Potential New Migraine Treatment

If you answered ‘yes’ to the above questions, you may be eligible to participate in a clinical trial for a potential new medication for treating migraine.
The study is being conducted at research sites located in:
New South Wales
Queensland
Victoria
Adelaide
You will receive study-related care and assessments at no cost.
You will be reimbursed for your travel and time.
Your participation in the study will be up to 3 months, with 3 clinic visits required.
To see if you qualify, please email Zave at [email protected] and they will contact you to discuss the study further.
This study has been approved by Bellberry Human Research Ethics Committee.